These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22615958)

  • 1. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.
    Kong J; Kong J; Pan B; Ke S; Dong S; Li X; Zhou A; Zheng L; Sun WB
    PLoS One; 2012; 7(5):e37266. PubMed ID: 22615958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1α.
    Wan J; Wu W; Huang Y; Ge W; Liu S
    Oncol Rep; 2016 Aug; 36(2):659-68. PubMed ID: 27278081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
    Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
    J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α and HIF-2α: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation.
    Wu L; Fu Z; Zhou S; Gong J; Liu CA; Qiao Z; Li S
    PLoS One; 2014; 9(2):e88913. PubMed ID: 24551189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma.
    Kong J; Kong L; Kong J; Ke S; Gao J; Ding X; Zheng L; Sun H; Sun W
    J Transl Med; 2012 Nov; 10():230. PubMed ID: 23171368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
    Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of hypoxia inducible factor-2α on promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation].
    Wu L; Zhou W; Zhou S; Liu C; Li S
    Zhonghua Gan Zang Bing Za Zhi; 2015 Feb; 23(2):112-7. PubMed ID: 25880977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo.
    Wu L; Zhou J; Zhou W; Huang XF; Chen Q; Wang W; Zhai L; Li S; Tang Z
    Pathol Res Pract; 2021 Apr; 220():153270. PubMed ID: 33640712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
    Cheng S; Zhang X; Xu Y; Dai X; Li J; Zhang T; Chen X
    Sci Rep; 2018 Nov; 8(1):17415. PubMed ID: 30479372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
    J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Andrographolide reduced VEGFA expression in hepatoma cancer cells by inactivating HIF-1α: The involvement of JNK and MTA1/HDCA.
    Shi L; Zhang G; Zheng Z; Lu B; Ji L
    Chem Biol Interact; 2017 Aug; 273():228-236. PubMed ID: 28651835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo.
    Xu M; Xie XH; Xie XY; Xu ZF; Liu GJ; Zheng YL; Huang GL; Wang W; Zheng SG; Lü MD
    Acta Radiol; 2013 Mar; 54(2):199-204. PubMed ID: 23171528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
    Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
    Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
    Zhang Y; Zhang Y; Wang J; Gu H
    Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2.
    Dong S; Li Z; Kong J; Wu S; Gao J; Sun W
    Int J Hyperthermia; 2022; 39(1):888-896. PubMed ID: 35848416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells.
    Xu M; Zheng YL; Xie XY; Liang JY; Pan FS; Zheng SG; Lü MD
    DNA Cell Biol; 2014 May; 33(5):275-81. PubMed ID: 24611881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.